Martina Biggioggero

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Over the last decades, the increasing knowledge in the area of rheumatoid arthritis has progressively expanded the arsenal of available drugs, especially with the introduction of novel targeted therapies such as biological disease modifying antirheumatic drugs (DMARDs). In this situation, rheumatologists are offered a wide range of treatment options, but on(More)
  • 1